Insurgent Medtech Jun 2017 - Dec 2018
Scientific Advisory Board
March For Science Nyc Nov 2017 - Sep 2018
Co Organizer 2018 March For Science Nyc
Springer Nature Nov 2017 - Sep 2018
Editor and Author, Neurotropic Viral Infections, 2Nd Edition
New York University Nov 2017 - Sep 2018
Co-Director Nyu Science Training Enhancement Program
Dna and Cell Biology A Mary Ann Liebert Publication Nov 2017 - Sep 2018
Editor-In-Chief
Education:
The City University of New York 1973 - 1978
Doctorates, Doctor of Philosophy, Microbiology, Immunology
Sarah Lawrence College 1971 - 1973
Master of Science, Masters, Genetics
Bryn Mawr College 1968 - 1972
Bachelors, Bachelor of Arts, Biology
Columbia Senior High School
Skills:
Immunology Molecular Biology Research Science Life Sciences Cell Biology Biochemistry Teaching Cell Culture Infectious Diseases Lifesciences Biotechnology Pcr Training Western Blotting Genetics Clinical Research Cell Microbiology Animal Models Public Health Neuroscience Scientific Writing Elisa Clinical Trials Genomics Higher Education Management Polymerase Chain Reaction Grant Writing Flow Cytometry Molecular Cloning Epidemiology Protein Expression Qualitative and Quantitative Research Methodologies Research Design Data Analysis Academic Writing Experimental Research Experimental Design
Interests:
Equity Viral Immunity Neuroimmunology Innate Immunity Women In Stem Careers
The present invention relates to recombinant replicable viral vectors and viruses which are modified with IL23. This IL23 modified virus is highly immunogenic and attenuated for neurotropic pathology found in the wild type viruses. These viruses and vectors can be used for treatment of a variety of cancers and for vaccination against many viral, bacterial, or parasitic diseases.
Method For Increasing The Permeability Of The Blood Brain Barrier
Carol Shoshkes Reiss - New York NY, US Takaishi Komatsu - Whitestone NY, US
Assignee:
New York University - New York NY
International Classification:
A01N 37/18
US Classification:
514 2
Abstract:
The present invention relates to a method for regulating the permeability of the blood brain barrier by administering a NOS-3 inhibitor to reduce the increased permeability of the blood brain barrier caused by a pathological condition or by administering a NOS-3 activator or nitric oxide donor to increase the permeability of the blood brain barrier. By increasing the permeability of the blood barrier, a therapeutic or diagnostic compound can be delivered across this barrier into the central nervous system.
Rasta Forjah, Raphe Breit, Alison White, Angela Tomlinson, Nicholas Cissna, James Galvin, Richie Miller, Deborah Frothingham, Andrew Harris, Brian Pikarski